Physician profile
Benjamin L Rucker
NPI 1255435525
$627.60
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $31.58 · 2021: $153 · 2022: $121 · 2023: $61.61 · 2024: $31.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $174.88 | 2019-2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $87.67 | 2021-2022 | |
| Lilly USA, LLC | $54.28 | 2021-2024 | Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $53.70 | 2019-2023 | |
| Novo Nordisk INC | $49.73 | 2019-2022 | |
| Pfizer INC. | $40.76 | 2019 | |
| Merck Sharp & Dohme LLC | $30.39 | 2019-2020 | |
| Allergan, INC. | $25.66 | 2019 | |
| Emmaus Medical, INC. | $22.71 | 2021 | |
| Nestle Healthcare Nutrition INC. | $17.43 | 2021 | |
| Glaxosmithkline, LLC. | $17.37 | 2023 | Trelegy Ellipta |
| Abbott Laboratories | $15.99 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.59 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Rucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.